/ /

  • linkedin
  • Increase Font
  • Sharebar

    IRIS Registry gives glimpse into DME in real world


    Looking at treatments administered beginning 28 days after initial diagnosis, the study found that 81% of patients who were initially observed continued to receive no treatment, while about 10% were started on anti-VEGF therapy and 7% were treated with laser.

    A logistic and multinomial regression analysis was performed to identify factors predicting treatment within the first 28 days.

    The results showed that patients were more likely to be started on anti-VEGF therapy than be observed if they were initially diagnosed by a retina specialist rather than by a non-retina provider and if they had bilateral versus unilateral DME.

    The odds of receiving laser treatment rather than being observed were significantly higher among patients seen in a non-urban versus urban setting and significantly lower in patients initially diagnosed with worse vision (<20/40 versus ≥20/40).

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results